Nationwide recall of Pillsbury flour due to salmonella fears
More than 12,000 cases of the unbleached flour have been sold nationwide at retailers including Meijer, Publix and Winn-Dixie
Kate Gibson is a Reporter for CBS MoneyWatch in New York, where she covers business and consumer finance. She previously worked for CNBC and MarketWatch and has written for national news outlets, including Barron's, the Wall Street Journal and the Chicago Tribune.
More than 12,000 cases of the unbleached flour have been sold nationwide at retailers including Meijer, Publix and Winn-Dixie
Federal watchdog finds potentially dangerous bacteria in one product and a skin-burning chemical in another
Investors don't seem to be buying one chief executive's unusual explanation for his company's poor financial results
Fashion retailer that sells women's and children's clothes will liquidate after 44 years
Retailing giant will shutter kiosks inside malls, Whole Foods and Kohl's stores across the country
He no longer has any role in Batali & Bastianch Hospitality Group, which runs 20 restaurants in six cities
Discount retailer to shutter or rebrand almost 600 locations and is even looking into pricing some items above a buck
Investment bank taking more flexible approach to what employees wear, saying people know what attire is appropriate
Travel site says it doesn't delete a business when something terrible happens there because it's "valuable information"
Toys R Us collapse prompts calls to treat laid-off workers the same as bankers and lawyers in bankruptcy courts
Crippling debt could push a number of other name retail chains over the edge this year, Moody's predicts
Drugmaker facing myriad lawsuits over its role in the opioid epidemic is weighing a Chapter 11 filing, Reuters reports
Insurers for CEO Tim Sloan, his predecessor and other executives will foot the latest bill from 2016 scandal
The biggest U.S. grocery chain said its Smith's stores will no longer accept the cards because of "excessive fees"
In recent months, multiple drugmakers have recalled medications after tests revealed traces of carcinogens